Indeed, studies indicate that HCV infection reduces the phosphorylation of AMPK at threonine 172 and concomitant AMPK activity, which is partially responsible for HCV-associated hepatic steatosis [18, 19]. The gene discussed is PRKAA1; the disease is fatty liver disease.